Expand PGEN Menu
PGEN MENU

Precigen (PGEN) closed at $5.25 on November 3, 2026, up 2.1% from the previous close, on volume of 9,317,377 shares (30-day average 5,497,396).

Key numbers
  • Last close: $5.25 (November 3, 2026)
  • 52-week range: $3.04 to $8.98
  • Market value: $1.9 billion
  • 30-day implied volatility (IV30): 89.5%
  • Option volume: 554 contracts (513 calls, 41 puts); 30-day average 3,017
  • Next earnings: November 4, 2026, after the market closes (confirmed)

Data as of November 3, 2026.

PGEN Stock Summary and Trading Ideas (Precigen | NASDAQ:PGEN)

Charts for Today's Stock Price and Implied Volatility in Precigen

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for PGEN by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Precigen (PGEN) Frequently Asked Questions

What does Precigen do?

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

What symbol and exchange does Precigen shares trade?

Precigen trades on the NASDAQ stock market under the symbol PGEN.

What is Precigen stock price doing today?

As of November 4, 2026, PGEN stock price declined to $4.88 with 3,837,175 million shares trading.

What is Precigen's Beta?

PGEN has a beta of 0.85, meaning it tends to be less sensitive to market movements. PGEN has a correlation of 0.02 to the broad based SPY ETF.

How much is Precigen worth?

PGEN has a market cap of $1.75 billion. This is considered a Small Cap stock.

How much money does Precigen make?

Last quarter Precigen reported $55 million in Revenue and $.05 earnings per share. This beat revenue expectation by $27 million and exceeded earnings estimates by $.06.

What is the highest and lowest price Precigen traded in the last 3 year period?

In the last 3 years, PGEN traded as high as $8.98 and as low as $.65.

What are the top ETFs holding Precigen?

The top ETF exchange traded funds that PGEN belongs to (by Net Assets): VTI, XBI, IWM, VXF, VTWO.

Is Precigen (PGEN) a good investment?

PGEN has outperformed the market in the last year with a return of +17.3%, while the SPY ETF gained +13.1%. However, in the most recent history, PGEN shares have underperformed the stock market with its stock returning -26.2% in the last 3 month period and -28.6% for the last 2 week period, while SPY has returned +1.2% and -0.5%, respectively.

What are the support and resistance levels for Precigen (PGEN)?

PGEN support price is $5.00 and resistance is $5.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGEN shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes